In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...

Enanta Pharmaceuticals (NASDAQ:ENTA) announced on Wednesday a lawsuit filed in the EU against Pfizer (NYSE:PFE) and some of ...

Enanta Pharmaceuticals ( ($ENTA) ) has shared an announcement. On August 20, 2025, Enanta Pharmaceuticals announced it filed a patent infringement ...

Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...

Enanta Pharmaceuticals (NETA) stock fell as the company plans to appeal a court ruling favoring Pfizer in a patent dispute over COVID-19 pill Paxlovid. Read more here.

Pfizer did not immediately respond to requests for comment. Enanta filed the patent in July 2020, two years before the U.S. Patent and Trademark Office approved it, according to a press release.

The patent in question, U.S. Patent No. 11,358,953, was claimed by Enanta to be infringed by Pfizer through the manufacture, use, and sale of Paxlovid.

Pfizer dominates the COVID drug market. This Watertown biotech wants to change that. Enanta Pharmaceuticals has started a clinical trial of a pill that it says could be safer than the pharma giant ...

Enanta plans to issue its full year and fiscal fourth quarter financial results press release on November 25, 2024. About Enanta Pharmaceuticals, Inc.

Company News Published12/24/2024, 07:05 AM Pfizer prevails in Enanta patent case over Covid-19 drug View all comments (0)0 ENTA -2.56% ...

Enanta seeks fair compensation for Pfizer’s use of a coronavirus 3CL protease inhibitor claimed in the ‘953 patent. About Enanta Pharmaceuticals, Inc.